ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 77 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $124,113,157 | +108.0% | 3,131,008 | 0.0% | 5.24% | +64.1% |
| Q4 2023 | $59,677,012 | +74.6% | 3,131,008 | +4.9% | 3.19% | +40.5% |
| Q3 2023 | $34,186,918 | +11.4% | 2,985,757 | 0.0% | 2.27% | +23.9% |
| Q2 2023 | $30,693,582 | +33.2% | 2,985,757 | 0.0% | 1.83% | +9.8% |
| Q1 2023 | $23,050,044 | +5.0% | 2,985,757 | 0.0% | 1.67% | +22.4% |
| Q4 2022 | $21,945,314 | +2.1% | 2,985,757 | 0.0% | 1.36% | -17.6% |
| Q3 2022 | $21,497,000 | -15.4% | 2,985,757 | 0.0% | 1.66% | -31.0% |
| Q2 2022 | $25,409,000 | -32.3% | 2,985,757 | -28.7% | 2.40% | -25.1% |
| Q1 2022 | $37,546,000 | – | 4,185,757 | – | 3.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,199,011 | $24,629,000 | 3.99% |
| BVF INC/IL | 675,759 | $7,569,000 | 0.91% |
| Orbimed Advisors | 3,298,516 | $36,943,000 | 0.47% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 913,100 | $10,227,000 | 0.40% |
| TIGER MANAGEMENT L.L.C. | 162,728 | $1,823,000 | 0.28% |
| Rock Springs Capital Management LP | 150,000 | $1,680,000 | 0.08% |
| Sowell Financial Services LLC | 15,714 | $168,000 | 0.04% |
| Spark Investment Management LLC | 16,600 | $185,000 | 0.01% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 10,000 | $112,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 38,750 | $434,000 | 0.01% |